These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10759342)

  • 1. Cost-effectiveness of fluoxetine plus pindolol in patients with major depressive disorder: results from a randomized, double-blind clinical trial.
    Sacristán JA; Gilaberte I; Boto B; Buesching DP; Obenchain RL; Demitrack M; Pérez Sola V; Alvarez E; Artigas F
    Int Clin Psychopharmacol; 2000 Mar; 15(2):107-13. PubMed ID: 10759342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic outcomes of eszopiclone treatment in insomnia and comorbid major depressive disorder.
    Snedecor SJ; Botteman MF; Schaefer K; Sarocco P; Barry N; Pickard AS
    J Ment Health Policy Econ; 2010 Mar; 13(1):27-35. PubMed ID: 20571180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial.
    Berman RM; Darnell AM; Miller HL; Anand A; Charney DS
    Am J Psychiatry; 1997 Jan; 154(1):37-43. PubMed ID: 8988956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in austria.
    Brown MC; Nimmerrichter AA; Guest JF
    Eur Psychiatry; 1999 Jul; 14(4):230-44. PubMed ID: 10572352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trial.
    Berman RM; Anand A; Cappiello A; Miller HL; Hu XS; Oren DA; Charney DS
    Biol Psychiatry; 1999 May; 45(9):1170-7. PubMed ID: 10331109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression.
    Maes M; Vandoolaeghe E; Desnyder R
    J Affect Disord; 1996 Dec; 41(3):201-10. PubMed ID: 8988452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment.
    Pérez V; Gilaberte I; Faries D; Alvarez E; Artigas F
    Lancet; 1997 May; 349(9065):1594-7. PubMed ID: 9174562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness study of a year follow-up of selective serotonin reuptake inhibitor (SSRI) and augmentor combination compared with SSRI and placebo.
    Tome MB; Isaac MT
    Int Clin Psychopharmacol; 1998 Jul; 13(4):175-82. PubMed ID: 9727728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative cost-effectiveness of treatments for adolescent depression: 36-week results from the TADS randomized trial.
    Domino ME; Foster EM; Vitiello B; Kratochvil CJ; Burns BJ; Silva SG; Reinecke MA; March JS
    J Am Acad Child Adolesc Psychiatry; 2009 Jul; 48(7):711-720. PubMed ID: 19465880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of fluoxetine's antidepressant action by pindolol: analysis of clinical, pharmacokinetic, and methodologic factors.
    Pérez V; Puiigdemont D; Gilaberte I; Alvarez E; Artigas F;
    J Clin Psychopharmacol; 2001 Feb; 21(1):36-45. PubMed ID: 11199945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Course and cost of treatment for depression with fluoxetine, paroxetine, and sertraline.
    Russell JM; Berndt ER; Miceli R; Colucci S; Grudzinski AN
    Am J Manag Care; 1999 May; 5(5):597-606. PubMed ID: 10537866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pindolol augmentation enhances response outcomes in first depressive episodes.
    Portella MJ; de Diego-Adeliño J; Puigdemont D; Pérez-Egea R; Alvarez E; Artigas F; Pérez V
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):516-9. PubMed ID: 19419845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoxetine and imipramine: are there differences in cost-utility for depression in primary care?
    Serrano-Blanco A; Suárez D; Pinto-Meza A; Peñarrubia MT; Haro JM;
    J Eval Clin Pract; 2009 Feb; 15(1):195-203. PubMed ID: 19239602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escitalopram: a pharmacoeconomic review of its use in depression.
    Croom KF; Plosker GL
    Pharmacoeconomics; 2003; 21(16):1185-209. PubMed ID: 14594439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance.
    Maes M; Libbrecht I; van Hunsel F; Campens D; Meltzer HY
    J Clin Psychopharmacol; 1999 Apr; 19(2):177-82. PubMed ID: 10211920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness of venlafaxine compared with generic fluoxetine or generic amitriptyline in major depressive disorder in the UK.
    Lenox-Smith A; Greenstreet L; Burslem K; Knight C
    Clin Drug Investig; 2009; 29(3):173-84. PubMed ID: 19243210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weekly dosing of fluoxetine for the continuation phase of treatment of major depression: results of a placebo-controlled, randomized clinical trial.
    Burke WJ; Hendricks SE; McArthur-Miller D; Jacques D; Bessette D; McKillup T; Stull T; Wilson J
    J Clin Psychopharmacol; 2000 Aug; 20(4):423-7. PubMed ID: 10917403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine in early poststroke depression: a double-blind placebo-controlled study.
    Wiart L; Petit H; Joseph PA; Mazaux JM; Barat M
    Stroke; 2000 Aug; 31(8):1829-32. PubMed ID: 10926942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paroxetine with pindolol augmentation: a double-blind, randomized, placebo-controlled study in depressed in-patients.
    Geretsegger C; Bitterlich W; Stelzig R; Stuppaeck C; Bondy B; Aichhorn W
    Eur Neuropsychopharmacol; 2008 Feb; 18(2):141-6. PubMed ID: 18054209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of adjuvant pindolol on the antiobsessional response to fluvoxamine: a double-blind, placebo-controlled study.
    Mundo E; Guglielmo E; Bellodi L
    Int Clin Psychopharmacol; 1998 Sep; 13(5):219-24. PubMed ID: 9817627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.